These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

365 related articles for article (PubMed ID: 18840411)

  • 21. Cellular FLICE-like inhibitory protein (c-FLIP): a novel target for Taxol-induced apoptosis.
    Day TW; Najafi F; Wu CH; Safa AR
    Biochem Pharmacol; 2006 May; 71(11):1551-61. PubMed ID: 16579975
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Early growth response-1 is a regulator of DR5-induced apoptosis in colon cancer cells.
    Mahalingam D; Natoni A; Keane M; Samali A; Szegezdi E
    Br J Cancer; 2010 Feb; 102(4):754-64. PubMed ID: 20087343
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Rapid up-regulation of c-FLIP expression by BCR signaling through the PI3K/Akt pathway inhibits simultaneously induced Fas-mediated apoptosis in murine B lymphocytes.
    Moriyama H; Yonehara S
    Immunol Lett; 2007 Mar; 109(1):36-46. PubMed ID: 17275920
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CCAAT/enhancer binding protein homologous protein-dependent death receptor 5 induction and ubiquitin/proteasome-mediated cellular FLICE-inhibitory protein down-regulation contribute to enhancement of tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis by dimethyl-celecoxib in human non small-cell lung cancer cells.
    Chen S; Liu X; Yue P; Schönthal AH; Khuri FR; Sun SY
    Mol Pharmacol; 2007 Nov; 72(5):1269-79. PubMed ID: 17684158
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Protective effect of RIP and c-FLIP in preventing liver cancer cell apoptosis induced by TRAIL.
    Sun J; Luo H; Nie W; Xu X; Miao X; Huang F; Wu H; Jin X
    Int J Clin Exp Pathol; 2015; 8(6):6519-25. PubMed ID: 26261530
    [TBL] [Abstract][Full Text] [Related]  

  • 26. PPARgamma ligands enhance TRAIL-induced apoptosis through DR5 upregulation and c-FLIP downregulation in human lung cancer cells.
    Zou W; Liu X; Yue P; Khuri FR; Sun SY
    Cancer Biol Ther; 2007 Jan; 6(1):99-106. PubMed ID: 17172826
    [TBL] [Abstract][Full Text] [Related]  

  • 27. c-FLIP inhibits chemotherapy-induced colorectal cancer cell death.
    Longley DB; Wilson TR; McEwan M; Allen WL; McDermott U; Galligan L; Johnston PG
    Oncogene; 2006 Feb; 25(6):838-48. PubMed ID: 16247474
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Selective knockdown of the long variant of cellular FLICE inhibitory protein augments death receptor-mediated caspase-8 activation and apoptosis.
    Sharp DA; Lawrence DA; Ashkenazi A
    J Biol Chem; 2005 May; 280(19):19401-9. PubMed ID: 15760909
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Caspase-8, c-FLIP, and caspase-9 in c-Myc-induced apoptosis of fibroblasts.
    Järvinen K; Hotti A; Santos L; Nummela P; Hölttä E
    Exp Cell Res; 2011 Nov; 317(18):2602-15. PubMed ID: 21903094
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Role of endoplasmic reticulum stress in alpha-TEA mediated TRAIL/DR5 death receptor dependent apoptosis.
    Tiwary R; Yu W; Li J; Park SK; Sanders BG; Kline K
    PLoS One; 2010 Jul; 5(7):e11865. PubMed ID: 20686688
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intracellular mechanisms of TRAIL: apoptosis through mitochondrial-dependent and -independent pathways.
    Suliman A; Lam A; Datta R; Srivastava RK
    Oncogene; 2001 Apr; 20(17):2122-33. PubMed ID: 11360196
    [TBL] [Abstract][Full Text] [Related]  

  • 32. FLIP overexpression inhibits death receptor-induced apoptosis in malignant mesothelial cells.
    Rippo MR; Moretti S; Vescovi S; Tomasetti M; Orecchia S; Amici G; Catalano A; Procopio A
    Oncogene; 2004 Oct; 23(47):7753-60. PubMed ID: 15334061
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ewing's sarcoma family tumors are sensitive to tumor necrosis factor-related apoptosis-inducing ligand and express death receptor 4 and death receptor 5.
    Mitsiades N; Poulaki V; Mitsiades C; Tsokos M
    Cancer Res; 2001 Mar; 61(6):2704-12. PubMed ID: 11289151
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Signaling through the TRAIL receptor DR5/FADD pathway plays a role in the apoptosis associated with skeletal myoblast differentiation.
    O'Flaherty J; Mei Y; Freer M; Weyman CM
    Apoptosis; 2006 Dec; 11(12):2103-13. PubMed ID: 17041756
    [TBL] [Abstract][Full Text] [Related]  

  • 35. 4-(4-Chloro-2-methylphenoxy)-N-hydroxybutanamide (CMH) targets mRNA of the c-FLIP variants and induces apoptosis in MCF-7 human breast cancer cells.
    Bijangi-Vishehsaraei K; Huang S; Safa AR; Saadatzadeh MR; Murphy MP
    Mol Cell Biochem; 2010 Sep; 342(1-2):133-142. PubMed ID: 20446019
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mechanisms of resistance to TRAIL-induced apoptosis in primary B cell chronic lymphocytic leukaemia.
    MacFarlane M; Harper N; Snowden RT; Dyer MJ; Barnett GA; Pringle JH; Cohen GM
    Oncogene; 2002 Oct; 21(44):6809-18. PubMed ID: 12360407
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Targeting c-FLIP in cancer.
    Shirley S; Micheau O
    Cancer Lett; 2013 May; 332(2):141-50. PubMed ID: 21071136
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Triggering of death receptor apoptotic signaling by human papillomavirus 16 E2 protein in cervical cancer cell lines is mediated by interaction with c-FLIP.
    Wang W; Fang Y; Sima N; Li Y; Li W; Li L; Han L; Liao S; Han Z; Gao Q; Li K; Deng D; Meng L; Zhou J; Wang S; Ma D
    Apoptosis; 2011 Jan; 16(1):55-66. PubMed ID: 20882347
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhibition of p38 mitogen-activated protein kinase unmasks a CD30-triggered apoptotic pathway in anaplastic large cell lymphoma cells.
    Krysov SV; Rowley TF; Al-Shamkhani A
    Mol Cancer Ther; 2007 Feb; 6(2):703-11. PubMed ID: 17308066
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Human retinoblastoma cells are resistant to apoptosis induced by death receptors: role of caspase-8 gene silencing.
    Poulaki V; Mitsiades CS; McMullan C; Fanourakis G; Negri J; Goudopoulou A; Halikias IX; Voutsinas G; Tseleni-Balafouta S; Miller JW; Mitsiades N
    Invest Ophthalmol Vis Sci; 2005 Jan; 46(1):358-66. PubMed ID: 15623796
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.